Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sleep-Wake Cycles

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

Sedatives and Hypnotics: Overview

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

Management of Insomnia

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...

Narcolepsy

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*).

Endoscopy·2003

Same author

Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.

Pharmacogenomics·2003

Same author

Study of a patient population investigated for excessive daytime sleepiness (EDS).

Neurophysiologie clinique = Clinical neurophysiology·2003

Same author

HLA and genetic susceptibility to sleepwalking.

Molecular psychiatry·2003

Same author

[Ultrasonic diagnosis of calciphylactic lesions].

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2003

Same author

Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses.

Neurology·2002

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Ritanserin improves sleep quality in narcolepsy.

¹Hephata Klinik, Schwalmstadt-Treysa, Germany. geert.mayer@hephata.com

Pharmacopsychiatry

|August 9, 2003

Summary

Ritanserin, a 5HT2-antagonist, improved morning refreshment in narcolepsy patients but did not significantly reduce daytime sleepiness or sleep attacks. It may help improve sleep quality as an add-on treatment.

Area of Science:

Neurology
Sleep Medicine
Pharmacology

Background:

Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness and disrupted sleep.
Ritanserin, a selective serotonin 5HT2-antagonist, has shown potential in improving sleep quality in narcolepsy patients.

Purpose of the Study:

To evaluate the efficacy of ritanserin in improving daytime sleepiness, sleep quality, and other narcolepsy symptoms.
To assess ritanserin's effects on slow-wave sleep and NREM stage 1 sleep in narcolepsy patients.

Main Methods:

A double-blind, placebo-controlled, multi-center study involving 134 narcolepsy patients.
Patients received 5 mg or 10 mg ritanserin, or placebo, daily for 28 days, with stable concomitant medications allowed.
Efficacy was assessed using polysomnography, visual analogue scales, and patient/clinician-rated questionnaires.

More Related Videos

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jul 10, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Main Results:

Ritanserin significantly improved the feeling of being refreshed in the morning but did not improve other subjective narcolepsy symptoms.
Objective measures showed a significant increase in nocturnal slow-wave sleep and a reduction in NREM stage 1 sleep with ritanserin.
Subjective improvements in daytime sleepiness and sleep attacks were not observed, despite polysomnographic changes.

Conclusions:

Ritanserin may be beneficial as an add-on therapy for improving sleep quality in narcolepsy patients.
It does not appear to function as a stimulant or hypnotic medication for narcolepsy symptom management.